P2.09-35 Amivantamab vs Real World Therapies for Advanced NSCLC with EGFR Exon20ins in China

Category Primary study
JournalJournal of Thoracic Oncology
Year 2023
This article has no abstract
Epistemonikos ID: a7fce1f355930145fe5561cb97bd9e3d76b135f4
First added on: Jun 13, 2024